Related Experiment Video
Updated: Nov 4, 2025

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
Endoscopic Transpapillary Gallbladder Drainage for Acute Cholecystitis using Two Gallbladder Stents (Dual Gallbladder
Zain A Sobani1, Sergio A Sánchez-Luna1, Tarun Rustagi1
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of New Mexico, NM, USA.
Dual endoscopic transpapillary gallbladder drainage (ETPGBD) offers a safe and effective solution for managing acute cholecystitis in high-risk patients, achieving high success rates and minimizing adverse events.
Area of Science:
- Gastroenterology
- Minimally Invasive Surgery
Background:
- Acute cholecystitis (AC) in high-risk patients often requires alternative management strategies.
- Endoscopic transpapillary gallbladder drainage (ETPGBD) is an emerging technique for AC.
- Stent obstruction is a known complication of ETPGBD.
Purpose of the Study:
- To describe and evaluate a novel dual-stenting technique for ETPGBD in AC.
- To assess the technical feasibility, safety, and efficacy of dual ETPGBD.
Main Methods:
- Retrospective analysis of 21 patients undergoing dual ETPGBD for AC (November 2017 - August 2020).
- Dual stents placed during the index procedure or an interval procedure (4-6 weeks later).
- Evaluation of technical/clinical success, adverse events, and long-term outcomes.
Main Results:
- 100% technical and clinical success rates observed.
- Low recurrence rate (4.76%) and adverse event rate (9.52%).
- Mean follow-up of 471.74 days demonstrated sustained efficacy.
Conclusions:
- Dual ETPGBD is a safe and effective method for long-term gallbladder drainage in non-surgical AC patients.
- Further controlled studies are warranted to confirm these findings for broader application.
Related Concept Videos
Endoscopic Procedures V: ERCP
Patient...
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:

